Aims : Hypertensive disorders in pregnancy remain a major cause of maternal and neonatal morbidity and mortality worldwide. This study prospectively examined the immediate neonatal outcome of women with maternal hypertensive disorder of pregnancy( HDP).Methods : Sixty mothers and their newborn were selected. Mothers with gestational hypertension, preeclampsia, preeclampsia superimposed on chronic hypertension and chronic hypertension were included.Results : Forty five (75%) mothers were mutipara and 15(25%) were primipara. Mean maternal age was 26.4 years. Mean gestational age was 34+ 4 weeks. 38 were male and 22 were female with Male: Female ratio was 1.72: 1. Thirty six (60%) were from in patient with regular antenatal check up, 60% mothers had gestational hypertension. Fifty four (90%) mothers needed lower uterine caesarian section. Forty four (73.33%) delivered preterm before 36 weeks of pregnancy. Low birth weight (<2.5kg) babies were 30(50%), very low birth weight (<1.5kg) were 16(26.66%). Intrauterine growth retardation (IUGR) were 18(30%) and Appropriate for gestational age( AGA) were 14(23.33%). Respiratory distress 30(50%) were the most common cause of admission, other associated problems were perinatal asphyxia (PNA) with seizure and meconium aspiration syndrome and to rule out sepsis in suspected cases. Nine (15%) needed ventilator care and 6(10%) needed nasal continuous positive airway pressure (NCPAP) for respiratory problem. 6(10%) babies were expired and 54(90%) survived. Average hospital stay were 18.32(±10.68) days with a highest hospital stay of 49 days and the lowest 4 days. Conclusion :Maternal hypertensive disorder of pregnancy is associated with neonatal morbidity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.